Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/bcp.70103
Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE) to forecast free prednisolone concentrations and its association with disease activity. Methods A total of 66 active SLE patients (adults and children) were included, and followed up prospectively (242 observations available). Plasma prednisolone concentrations were assessed using liquid chromatography‐mass spectrometry, and the data were analysed using Monolix software. The pharmacokinetic model was a one‐compartment open model with absorption lag time representing the delay for both absorption and metabolism from inactive (prednisone) to active form (prednisolone). This model predicted free concentrations, which were then used to calculate total concentrations based on established binding constants. Results Free prednisolone clearance (CLu/F) and volume of distribution (Vu/F) were scaled allometrically to body weight. The typical population estimates (95% confidence interval) were 54 (48–62) L/h/70 kg and 235 (203–274) L/70 kg, respectively. Additionally, the bioavailability parameter was found to decrease non‐linearly with the dose. Prednisolone cumulative exposure was not different between patients who responded at 3 months and those who did not. Conclusions Robust pharmacokinetic targets are not yet clearly defined regarding toxicity or efficacy and are warranted in order to make a valuable contribution to prednisolone therapeutic drug monitoring in the context of SLE.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/bcp.70103
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bcp.70103
- OA Status
- hybrid
- References
- 34
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4410693120
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4410693120Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/bcp.70103Digital Object Identifier
- Title
-
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-05-23Full publication date if available
- Authors
-
Naïm Bouazza, Michaëla Semeraro, Gabrielle Lui, Léo Froelicher Bournaud, Laure Choupeaux, Jean‐Marc Tréluyer, Sihem Benaboud, Joelle Terzic, Eric Hachulla, Philippe Rémy, Jérôme Harambat, Alexandre Karras, Caroline Rousset‐Rouvière, Anne Jolivot, Zahir Amoura, Éric Daugas, Aurélie Hummel, Rémi Salomon, Jean‐Christophe Lega, Stéphane Decramer, Alexandre Bélot, Delphine Gobert, N. Costedoat‐Chalumeau, Stanislas Faguer, Isabelle Melki, Noémie Jourde‐Chiche, Brigitte Bader‐MeunierList of authors in order
- Landing page
-
https://doi.org/10.1002/bcp.70103Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bcp.70103Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bcp.70103Direct OA link when available
- Concepts
-
Prednisolone, Prednisone, Volume of distribution, Pharmacokinetics, Medicine, Population, Pharmacology, Internal medicine, Context (archaeology), Biology, Paleontology, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
34Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4410693120 |
|---|---|
| doi | https://doi.org/10.1002/bcp.70103 |
| ids.doi | https://doi.org/10.1002/bcp.70103 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40411119 |
| ids.openalex | https://openalex.org/W4410693120 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D008180 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Lupus Erythematosus, Systemic |
| mesh[2].qualifier_ui | Q000097 |
| mesh[2].descriptor_ui | D008180 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | blood |
| mesh[2].descriptor_name | Lupus Erythematosus, Systemic |
| mesh[3].qualifier_ui | Q000493 |
| mesh[3].descriptor_ui | D011239 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | pharmacokinetics |
| mesh[3].descriptor_name | Prednisolone |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D011239 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Prednisolone |
| mesh[5].qualifier_ui | Q000097 |
| mesh[5].descriptor_ui | D011239 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | blood |
| mesh[5].descriptor_name | Prednisolone |
| mesh[6].qualifier_ui | Q000627 |
| mesh[6].descriptor_ui | D011239 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | therapeutic use |
| mesh[6].descriptor_name | Prednisolone |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D008297 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Male |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000328 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Adult |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D008954 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Models, Biological |
| mesh[11].qualifier_ui | Q000493 |
| mesh[11].descriptor_ui | D005938 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | pharmacokinetics |
| mesh[11].descriptor_name | Glucocorticoids |
| mesh[12].qualifier_ui | Q000008 |
| mesh[12].descriptor_ui | D005938 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | administration & dosage |
| mesh[12].descriptor_name | Glucocorticoids |
| mesh[13].qualifier_ui | Q000097 |
| mesh[13].descriptor_ui | D005938 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | blood |
| mesh[13].descriptor_name | Glucocorticoids |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D005938 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Glucocorticoids |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D008875 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Middle Aged |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D002648 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Child |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000293 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Adolescent |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D055815 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Young Adult |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D011446 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Prospective Studies |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D001682 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Biological Availability |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D012720 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Severity of Illness Index |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D005500 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Follow-Up Studies |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | Q000188 |
| mesh[24].descriptor_ui | D008180 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | drug therapy |
| mesh[24].descriptor_name | Lupus Erythematosus, Systemic |
| mesh[25].qualifier_ui | Q000097 |
| mesh[25].descriptor_ui | D008180 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | blood |
| mesh[25].descriptor_name | Lupus Erythematosus, Systemic |
| mesh[26].qualifier_ui | Q000493 |
| mesh[26].descriptor_ui | D011239 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | pharmacokinetics |
| mesh[26].descriptor_name | Prednisolone |
| mesh[27].qualifier_ui | Q000008 |
| mesh[27].descriptor_ui | D011239 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | administration & dosage |
| mesh[27].descriptor_name | Prednisolone |
| mesh[28].qualifier_ui | Q000097 |
| mesh[28].descriptor_ui | D011239 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | blood |
| mesh[28].descriptor_name | Prednisolone |
| mesh[29].qualifier_ui | Q000627 |
| mesh[29].descriptor_ui | D011239 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | therapeutic use |
| mesh[29].descriptor_name | Prednisolone |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D005260 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Female |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D008297 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Male |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D000328 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Adult |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D008954 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Models, Biological |
| mesh[34].qualifier_ui | Q000493 |
| mesh[34].descriptor_ui | D005938 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | pharmacokinetics |
| mesh[34].descriptor_name | Glucocorticoids |
| mesh[35].qualifier_ui | Q000008 |
| mesh[35].descriptor_ui | D005938 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | administration & dosage |
| mesh[35].descriptor_name | Glucocorticoids |
| mesh[36].qualifier_ui | Q000097 |
| mesh[36].descriptor_ui | D005938 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | blood |
| mesh[36].descriptor_name | Glucocorticoids |
| mesh[37].qualifier_ui | Q000627 |
| mesh[37].descriptor_ui | D005938 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | therapeutic use |
| mesh[37].descriptor_name | Glucocorticoids |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D008875 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Middle Aged |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D002648 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Child |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D000293 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Adolescent |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D055815 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Young Adult |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D011446 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Prospective Studies |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D001682 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Biological Availability |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D012720 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Severity of Illness Index |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D005500 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Follow-Up Studies |
| type | article |
| title | Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity |
| biblio.issue | 10 |
| biblio.volume | 91 |
| biblio.last_page | 2864 |
| biblio.first_page | 2854 |
| topics[0].id | https://openalex.org/T10308 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2745 |
| topics[0].subfield.display_name | Rheumatology |
| topics[0].display_name | Systemic Lupus Erythematosus Research |
| topics[1].id | https://openalex.org/T11016 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9958999752998352 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | Monoclonal and Polyclonal Antibodies Research |
| topics[2].id | https://openalex.org/T10031 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9876999855041504 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | T-cell and B-cell Immunology |
| is_xpac | False |
| apc_list.value | 4330 |
| apc_list.currency | USD |
| apc_list.value_usd | 4330 |
| apc_paid.value | 4330 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4330 |
| concepts[0].id | https://openalex.org/C2776715498 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9001454710960388 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11426176 |
| concepts[0].display_name | Prednisolone |
| concepts[1].id | https://openalex.org/C2778720950 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7011023163795471 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q424972 |
| concepts[1].display_name | Prednisone |
| concepts[2].id | https://openalex.org/C139254425 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6004208326339722 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1332167 |
| concepts[2].display_name | Volume of distribution |
| concepts[3].id | https://openalex.org/C112705442 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5934781432151794 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q323936 |
| concepts[3].display_name | Pharmacokinetics |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.575087308883667 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C2908647359 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5688242316246033 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[5].display_name | Population |
| concepts[6].id | https://openalex.org/C98274493 |
| concepts[6].level | 1 |
| concepts[6].score | 0.49165135622024536 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[6].display_name | Pharmacology |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4563491940498352 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C2779343474 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4459569454193115 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3109175 |
| concepts[8].display_name | Context (archaeology) |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.1351882517337799 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C151730666 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[10].display_name | Paleontology |
| concepts[11].id | https://openalex.org/C99454951 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[11].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/prednisolone |
| keywords[0].score | 0.9001454710960388 |
| keywords[0].display_name | Prednisolone |
| keywords[1].id | https://openalex.org/keywords/prednisone |
| keywords[1].score | 0.7011023163795471 |
| keywords[1].display_name | Prednisone |
| keywords[2].id | https://openalex.org/keywords/volume-of-distribution |
| keywords[2].score | 0.6004208326339722 |
| keywords[2].display_name | Volume of distribution |
| keywords[3].id | https://openalex.org/keywords/pharmacokinetics |
| keywords[3].score | 0.5934781432151794 |
| keywords[3].display_name | Pharmacokinetics |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.575087308883667 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/population |
| keywords[5].score | 0.5688242316246033 |
| keywords[5].display_name | Population |
| keywords[6].id | https://openalex.org/keywords/pharmacology |
| keywords[6].score | 0.49165135622024536 |
| keywords[6].display_name | Pharmacology |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.4563491940498352 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/context |
| keywords[8].score | 0.4459569454193115 |
| keywords[8].display_name | Context (archaeology) |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.1351882517337799 |
| keywords[9].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1002/bcp.70103 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S13842274 |
| locations[0].source.issn | 0306-5251, 1365-2125 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0306-5251 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | British Journal of Clinical Pharmacology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bcp.70103 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | British Journal of Clinical Pharmacology |
| locations[0].landing_page_url | https://doi.org/10.1002/bcp.70103 |
| locations[1].id | pmid:40411119 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | British journal of clinical pharmacology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40411119 |
| locations[2].id | pmh:oai:HAL:hal-05144962v1 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306402512 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[2].source.host_organization | https://openalex.org/I1294671590 |
| locations[2].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[2].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal articles |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | British Journal of Clinical Pharmacology, 2025, ⟨10.1002/bcp.70103⟩ |
| locations[2].landing_page_url | https://hal.science/hal-05144962 |
| locations[3].id | pmh:oai:europepmc.org:11272957 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12464645 |
| locations[4].id | pmh:oai:oskar-bordeaux.fr:20.500.12278/207222 |
| locations[4].is_oa | False |
| locations[4].source.id | https://openalex.org/S4306402569 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Oskar-Bordeaux (Universite de Bordeaux) |
| locations[4].source.host_organization | |
| locations[4].source.host_organization_name | |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Article de revue |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | https://oskar-bordeaux.fr/handle/20.500.12278/207222 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5089598609 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2158-1399 |
| authorships[0].author.display_name | Naïm Bouazza |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I204730241, https://openalex.org/I4210091437 |
| authorships[0].affiliations[0].raw_affiliation_string | Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I154526488 |
| authorships[0].affiliations[1].raw_affiliation_string | CIC‐1419 Inserm, Cochin‐Necker Paris France |
| authorships[0].affiliations[2].raw_affiliation_string | Unité de Recherche Clinique Necker Cochin AP‐HP France |
| authorships[0].institutions[0].id | https://openalex.org/I154526488 |
| authorships[0].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Inserm |
| authorships[0].institutions[1].id | https://openalex.org/I4210091437 |
| authorships[0].institutions[1].ror | https://ror.org/001z21q04 |
| authorships[0].institutions[1].type | other |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210091437 |
| authorships[0].institutions[1].country_code | FR |
| authorships[0].institutions[1].display_name | Sorbonne Paris Cité |
| authorships[0].institutions[2].id | https://openalex.org/I204730241 |
| authorships[0].institutions[2].ror | https://ror.org/05f82e368 |
| authorships[0].institutions[2].type | education |
| authorships[0].institutions[2].lineage | https://openalex.org/I204730241 |
| authorships[0].institutions[2].country_code | FR |
| authorships[0].institutions[2].display_name | Université Paris Cité |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Naïm Bouazza |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | CIC‐1419 Inserm, Cochin‐Necker Paris France, Unité de Recherche Clinique Necker Cochin AP‐HP France, Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[1].author.id | https://openalex.org/A5017005000 |
| authorships[1].author.orcid | https://orcid.org/0009-0005-7255-1922 |
| authorships[1].author.display_name | Michaëla Semeraro |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I204730241, https://openalex.org/I4210091437 |
| authorships[1].affiliations[0].raw_affiliation_string | Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I154526488 |
| authorships[1].affiliations[1].raw_affiliation_string | CIC‐1419 Inserm, Cochin‐Necker Paris France |
| authorships[1].institutions[0].id | https://openalex.org/I154526488 |
| authorships[1].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Inserm |
| authorships[1].institutions[1].id | https://openalex.org/I4210091437 |
| authorships[1].institutions[1].ror | https://ror.org/001z21q04 |
| authorships[1].institutions[1].type | other |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210091437 |
| authorships[1].institutions[1].country_code | FR |
| authorships[1].institutions[1].display_name | Sorbonne Paris Cité |
| authorships[1].institutions[2].id | https://openalex.org/I204730241 |
| authorships[1].institutions[2].ror | https://ror.org/05f82e368 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I204730241 |
| authorships[1].institutions[2].country_code | FR |
| authorships[1].institutions[2].display_name | Université Paris Cité |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Michaela Semeraro |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | CIC‐1419 Inserm, Cochin‐Necker Paris France, Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[2].author.id | https://openalex.org/A5055866468 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6529-0024 |
| authorships[2].author.display_name | Gabrielle Lui |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I204730241, https://openalex.org/I4210091437 |
| authorships[2].affiliations[0].raw_affiliation_string | Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I154526488 |
| authorships[2].affiliations[1].raw_affiliation_string | CIC‐1419 Inserm, Cochin‐Necker Paris France |
| authorships[2].affiliations[2].institution_ids | https://openalex.org/I4210092774, https://openalex.org/I4210124464 |
| authorships[2].affiliations[2].raw_affiliation_string | Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France |
| authorships[2].institutions[0].id | https://openalex.org/I4210124464 |
| authorships[2].institutions[0].ror | https://ror.org/02v5bgz72 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale |
| authorships[2].institutions[1].id | https://openalex.org/I4210092774 |
| authorships[2].institutions[1].ror | https://ror.org/00ph8tk69 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210092774, https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[2].institutions[1].country_code | FR |
| authorships[2].institutions[1].display_name | Hôpital Cochin |
| authorships[2].institutions[2].id | https://openalex.org/I154526488 |
| authorships[2].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[2].institutions[2].type | government |
| authorships[2].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[2].institutions[2].country_code | FR |
| authorships[2].institutions[2].display_name | Inserm |
| authorships[2].institutions[3].id | https://openalex.org/I4210091437 |
| authorships[2].institutions[3].ror | https://ror.org/001z21q04 |
| authorships[2].institutions[3].type | other |
| authorships[2].institutions[3].lineage | https://openalex.org/I4210091437 |
| authorships[2].institutions[3].country_code | FR |
| authorships[2].institutions[3].display_name | Sorbonne Paris Cité |
| authorships[2].institutions[4].id | https://openalex.org/I204730241 |
| authorships[2].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[2].institutions[4].type | education |
| authorships[2].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[2].institutions[4].country_code | FR |
| authorships[2].institutions[4].display_name | Université Paris Cité |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Gabrielle Lui |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | CIC‐1419 Inserm, Cochin‐Necker Paris France, Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France, Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[3].author.id | https://openalex.org/A5093025522 |
| authorships[3].author.orcid | https://orcid.org/0009-0001-3950-7728 |
| authorships[3].author.display_name | Léo Froelicher Bournaud |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210092774, https://openalex.org/I4210124464 |
| authorships[3].affiliations[0].raw_affiliation_string | Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210091437 |
| authorships[3].affiliations[1].raw_affiliation_string | Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[3].institutions[0].id | https://openalex.org/I4210124464 |
| authorships[3].institutions[0].ror | https://ror.org/02v5bgz72 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale |
| authorships[3].institutions[1].id | https://openalex.org/I4210092774 |
| authorships[3].institutions[1].ror | https://ror.org/00ph8tk69 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210092774, https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[3].institutions[1].country_code | FR |
| authorships[3].institutions[1].display_name | Hôpital Cochin |
| authorships[3].institutions[2].id | https://openalex.org/I154526488 |
| authorships[3].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[3].institutions[2].type | government |
| authorships[3].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[3].institutions[2].country_code | FR |
| authorships[3].institutions[2].display_name | Inserm |
| authorships[3].institutions[3].id | https://openalex.org/I4210091437 |
| authorships[3].institutions[3].ror | https://ror.org/001z21q04 |
| authorships[3].institutions[3].type | other |
| authorships[3].institutions[3].lineage | https://openalex.org/I4210091437 |
| authorships[3].institutions[3].country_code | FR |
| authorships[3].institutions[3].display_name | Sorbonne Paris Cité |
| authorships[3].institutions[4].id | https://openalex.org/I204730241 |
| authorships[3].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[3].institutions[4].type | education |
| authorships[3].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[3].institutions[4].country_code | FR |
| authorships[3].institutions[4].display_name | Université Paris Cité |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Léo Froelicher‐Bournaud |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France, Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[4].author.id | https://openalex.org/A5090434136 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Laure Choupeaux |
| authorships[4].affiliations[0].raw_affiliation_string | Unité de Recherche Clinique Necker Cochin AP‐HP France |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Laure Choupeaux |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Unité de Recherche Clinique Necker Cochin AP‐HP France |
| authorships[5].author.id | https://openalex.org/A5089989719 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2045-4742 |
| authorships[5].author.display_name | Jean‐Marc Tréluyer |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].raw_affiliation_string | Unité de Recherche Clinique Necker Cochin AP‐HP France |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210092774, https://openalex.org/I4210124464 |
| authorships[5].affiliations[1].raw_affiliation_string | Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France |
| authorships[5].affiliations[2].institution_ids | https://openalex.org/I204730241, https://openalex.org/I4210091437 |
| authorships[5].affiliations[2].raw_affiliation_string | Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[5].affiliations[3].institution_ids | https://openalex.org/I154526488 |
| authorships[5].affiliations[3].raw_affiliation_string | CIC‐1419 Inserm, Cochin‐Necker Paris France |
| authorships[5].institutions[0].id | https://openalex.org/I4210124464 |
| authorships[5].institutions[0].ror | https://ror.org/02v5bgz72 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale |
| authorships[5].institutions[1].id | https://openalex.org/I4210092774 |
| authorships[5].institutions[1].ror | https://ror.org/00ph8tk69 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210092774, https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[5].institutions[1].country_code | FR |
| authorships[5].institutions[1].display_name | Hôpital Cochin |
| authorships[5].institutions[2].id | https://openalex.org/I154526488 |
| authorships[5].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[5].institutions[2].type | government |
| authorships[5].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[5].institutions[2].country_code | FR |
| authorships[5].institutions[2].display_name | Inserm |
| authorships[5].institutions[3].id | https://openalex.org/I4210091437 |
| authorships[5].institutions[3].ror | https://ror.org/001z21q04 |
| authorships[5].institutions[3].type | other |
| authorships[5].institutions[3].lineage | https://openalex.org/I4210091437 |
| authorships[5].institutions[3].country_code | FR |
| authorships[5].institutions[3].display_name | Sorbonne Paris Cité |
| authorships[5].institutions[4].id | https://openalex.org/I204730241 |
| authorships[5].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[5].institutions[4].type | education |
| authorships[5].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[5].institutions[4].country_code | FR |
| authorships[5].institutions[4].display_name | Université Paris Cité |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jean‐Marc Treluyer |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | CIC‐1419 Inserm, Cochin‐Necker Paris France, Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France, Unité de Recherche Clinique Necker Cochin AP‐HP France, Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[6].author.id | https://openalex.org/A5036305862 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Sihem Benaboud |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210091437 |
| authorships[6].affiliations[0].raw_affiliation_string | Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210092774, https://openalex.org/I4210124464 |
| authorships[6].affiliations[1].raw_affiliation_string | Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France |
| authorships[6].institutions[0].id | https://openalex.org/I4210124464 |
| authorships[6].institutions[0].ror | https://ror.org/02v5bgz72 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale |
| authorships[6].institutions[1].id | https://openalex.org/I4210092774 |
| authorships[6].institutions[1].ror | https://ror.org/00ph8tk69 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210092774, https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[6].institutions[1].country_code | FR |
| authorships[6].institutions[1].display_name | Hôpital Cochin |
| authorships[6].institutions[2].id | https://openalex.org/I154526488 |
| authorships[6].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[6].institutions[2].type | government |
| authorships[6].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[6].institutions[2].country_code | FR |
| authorships[6].institutions[2].display_name | Inserm |
| authorships[6].institutions[3].id | https://openalex.org/I4210091437 |
| authorships[6].institutions[3].ror | https://ror.org/001z21q04 |
| authorships[6].institutions[3].type | other |
| authorships[6].institutions[3].lineage | https://openalex.org/I4210091437 |
| authorships[6].institutions[3].country_code | FR |
| authorships[6].institutions[3].display_name | Sorbonne Paris Cité |
| authorships[6].institutions[4].id | https://openalex.org/I204730241 |
| authorships[6].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[6].institutions[4].type | education |
| authorships[6].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[6].institutions[4].country_code | FR |
| authorships[6].institutions[4].display_name | Université Paris Cité |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Sihem Benaboud |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Service de Pharmacologie Clinique, Hôpital Cochin, AP‐HP, Groupe Hospitalier Paris Centre France, Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France |
| authorships[7].author.id | https://openalex.org/A5113914374 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Joelle Terzic |
| authorships[7].affiliations[0].raw_affiliation_string | Nephrology Dialysis Transplantation Children's Unit University Hospital Hautepierre Strasbourg France |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Joelle Terzic |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Nephrology Dialysis Transplantation Children's Unit University Hospital Hautepierre Strasbourg France |
| authorships[8].author.id | https://openalex.org/A5107944155 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Eric Hachulla |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I2279609970, https://openalex.org/I3018718406, https://openalex.org/I4210155195, https://openalex.org/I4387152267 |
| authorships[8].affiliations[0].raw_affiliation_string | Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Hôpital Claude Huriez, CERAINOM, U1286 ‐ INFINITE ‐ Institute for Translational Research in Inflammation Lille France |
| authorships[8].institutions[0].id | https://openalex.org/I4387152267 |
| authorships[8].institutions[0].ror | https://ror.org/03qy9z186 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I2279609970, https://openalex.org/I3018718406, https://openalex.org/I4387152267 |
| authorships[8].institutions[0].country_code | |
| authorships[8].institutions[0].display_name | Institute for Translational Research in Inflammation |
| authorships[8].institutions[1].id | https://openalex.org/I3018718406 |
| authorships[8].institutions[1].ror | https://ror.org/02ppyfa04 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I3018718406 |
| authorships[8].institutions[1].country_code | FR |
| authorships[8].institutions[1].display_name | Centre Hospitalier Universitaire de Lille |
| authorships[8].institutions[2].id | https://openalex.org/I4210155195 |
| authorships[8].institutions[2].ror | https://ror.org/05cpv3t46 |
| authorships[8].institutions[2].type | healthcare |
| authorships[8].institutions[2].lineage | https://openalex.org/I3018718406, https://openalex.org/I4210155195 |
| authorships[8].institutions[2].country_code | FR |
| authorships[8].institutions[2].display_name | Hôpital Claude Huriez |
| authorships[8].institutions[3].id | https://openalex.org/I154526488 |
| authorships[8].institutions[3].ror | https://ror.org/02vjkv261 |
| authorships[8].institutions[3].type | government |
| authorships[8].institutions[3].lineage | https://openalex.org/I154526488 |
| authorships[8].institutions[3].country_code | FR |
| authorships[8].institutions[3].display_name | Inserm |
| authorships[8].institutions[4].id | https://openalex.org/I2279609970 |
| authorships[8].institutions[4].ror | https://ror.org/02kzqn938 |
| authorships[8].institutions[4].type | education |
| authorships[8].institutions[4].lineage | https://openalex.org/I2279609970 |
| authorships[8].institutions[4].country_code | FR |
| authorships[8].institutions[4].display_name | Université de Lille |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Eric Hachulla |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Hôpital Claude Huriez, CERAINOM, U1286 ‐ INFINITE ‐ Institute for Translational Research in Inflammation Lille France |
| authorships[9].author.id | https://openalex.org/A5025017467 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2150-2563 |
| authorships[9].author.display_name | Philippe Rémy |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210105451, https://openalex.org/I4210130325 |
| authorships[9].affiliations[0].raw_affiliation_string | Assistance Publique des Hôpitaux de Paris (AP‐HP), Hôpitaux Universitaires Henri Mondor Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare «Syndrome Néphrotique Idiopathique», Fédération Hospitalo‐Universitaire "Innovative Therapy for Immune Disorders" Créteil France |
| authorships[9].institutions[0].id | https://openalex.org/I4210105451 |
| authorships[9].institutions[0].ror | https://ror.org/00yyw0g86 |
| authorships[9].institutions[0].type | other |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210105451 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine |
| authorships[9].institutions[1].id | https://openalex.org/I4210130325 |
| authorships[9].institutions[1].ror | https://ror.org/033yb0967 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210130325 |
| authorships[9].institutions[1].country_code | FR |
| authorships[9].institutions[1].display_name | Hôpitaux Universitaires Henri-Mondor |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Philippe Remy |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Assistance Publique des Hôpitaux de Paris (AP‐HP), Hôpitaux Universitaires Henri Mondor Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare «Syndrome Néphrotique Idiopathique», Fédération Hospitalo‐Universitaire "Innovative Therapy for Immune Disorders" Créteil France |
| authorships[10].author.id | https://openalex.org/A5016762535 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-2016-120X |
| authorships[10].author.display_name | Jérôme Harambat |
| authorships[10].affiliations[0].raw_affiliation_string | Pediatric Nephrology Unit, Reference Center for Rare Kidney Diseases, SORARE Bordeaux University Hospital Bordeaux France |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Jérôme Harambat |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Pediatric Nephrology Unit, Reference Center for Rare Kidney Diseases, SORARE Bordeaux University Hospital Bordeaux France |
| authorships[11].author.id | https://openalex.org/A5025424518 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-3075-7739 |
| authorships[11].author.display_name | Alexandre Karras |
| authorships[11].countries | FR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I204730241, https://openalex.org/I4210097159, https://openalex.org/I4210102325 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Nephrology Georges Pompidou European Hospital, Assistance Publique ‐ Hôpitaux de Paris, Paris, France; Université Paris Cité, Unité de Formation et de Recherche de Médecine Paris France |
| authorships[11].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[11].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[11].institutions[0].country_code | FR |
| authorships[11].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[11].institutions[1].id | https://openalex.org/I4210102325 |
| authorships[11].institutions[1].ror | https://ror.org/016vx5156 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210102325, https://openalex.org/I4210120235 |
| authorships[11].institutions[1].country_code | FR |
| authorships[11].institutions[1].display_name | Hôpital Européen Georges-Pompidou |
| authorships[11].institutions[2].id | https://openalex.org/I204730241 |
| authorships[11].institutions[2].ror | https://ror.org/05f82e368 |
| authorships[11].institutions[2].type | education |
| authorships[11].institutions[2].lineage | https://openalex.org/I204730241 |
| authorships[11].institutions[2].country_code | FR |
| authorships[11].institutions[2].display_name | Université Paris Cité |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Alexandre Karras |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Nephrology Georges Pompidou European Hospital, Assistance Publique ‐ Hôpitaux de Paris, Paris, France; Université Paris Cité, Unité de Formation et de Recherche de Médecine Paris France |
| authorships[12].author.id | https://openalex.org/A5042938950 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Caroline Rousset‐Rouvière |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210087487, https://openalex.org/I4210162909 |
| authorships[12].affiliations[0].raw_affiliation_string | Service de pédiatrie multidisciplinaire, Hôpital de la Timone, Assistance Publique‐Hôpitaux de Marseille Marseille France |
| authorships[12].institutions[0].id | https://openalex.org/I4210087487 |
| authorships[12].institutions[0].ror | https://ror.org/002cp4060 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210087487 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Assistance Publique Hôpitaux de Marseille |
| authorships[12].institutions[1].id | https://openalex.org/I4210162909 |
| authorships[12].institutions[1].ror | https://ror.org/05jrr4320 |
| authorships[12].institutions[1].type | healthcare |
| authorships[12].institutions[1].lineage | https://openalex.org/I4210087487, https://openalex.org/I4210162909 |
| authorships[12].institutions[1].country_code | FR |
| authorships[12].institutions[1].display_name | Hôpital de la Timone |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Caroline Rousset‐Rouviere |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Service de pédiatrie multidisciplinaire, Hôpital de la Timone, Assistance Publique‐Hôpitaux de Marseille Marseille France |
| authorships[13].author.id | https://openalex.org/A5102746585 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-5301-1366 |
| authorships[13].author.display_name | Anne Jolivot |
| authorships[13].countries | FR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210100596, https://openalex.org/I4210123600 |
| authorships[13].affiliations[0].raw_affiliation_string | Service de néphrologie, Hospices civils de Lyon, Hôpital Édouard Herriot Lyon France |
| authorships[13].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[13].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[13].institutions[0].country_code | FR |
| authorships[13].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[13].institutions[1].id | https://openalex.org/I4210123600 |
| authorships[13].institutions[1].ror | https://ror.org/02qt1p572 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I4210100596, https://openalex.org/I4210123600 |
| authorships[13].institutions[1].country_code | FR |
| authorships[13].institutions[1].display_name | Hôpital Edouard Herriot |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Anne Jolivot |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Service de néphrologie, Hospices civils de Lyon, Hôpital Édouard Herriot Lyon France |
| authorships[14].author.id | https://openalex.org/A5010498721 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Zahir Amoura |
| authorships[14].countries | FR |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[14].affiliations[0].raw_affiliation_string | Internal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique‐Hôpitaux de Paris, Pitié‐Salpêtrière Hospital Paris France |
| authorships[14].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[14].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[14].institutions[0].country_code | FR |
| authorships[14].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[14].institutions[1].id | https://openalex.org/I4210121705 |
| authorships[14].institutions[1].ror | https://ror.org/02mh9a093 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[14].institutions[1].country_code | FR |
| authorships[14].institutions[1].display_name | Pitié-Salpêtrière Hospital |
| authorships[14].institutions[2].id | https://openalex.org/I39804081 |
| authorships[14].institutions[2].ror | https://ror.org/02en5vm52 |
| authorships[14].institutions[2].type | education |
| authorships[14].institutions[2].lineage | https://openalex.org/I39804081 |
| authorships[14].institutions[2].country_code | FR |
| authorships[14].institutions[2].display_name | Sorbonne Université |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Zahir Amoura |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Internal Medicine Department 2, French National Referral Center for Rare Systemic Diseases and Histiocytoses, Sorbonne University, Assistance Publique‐Hôpitaux de Paris, Pitié‐Salpêtrière Hospital Paris France |
| authorships[15].author.id | https://openalex.org/A5044141185 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-7256-7979 |
| authorships[15].author.display_name | Éric Daugas |
| authorships[15].countries | FR |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I100532134, https://openalex.org/I4210145170 |
| authorships[15].affiliations[0].raw_affiliation_string | Service de Néphrologie, Assistance publique ‐ Hôpitaux de Paris (AP‐HP), Hôpital Bichat‐Claude Bernard Paris France |
| authorships[15].institutions[0].id | https://openalex.org/I4210145170 |
| authorships[15].institutions[0].ror | https://ror.org/03fdnmv92 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210145170 |
| authorships[15].institutions[0].country_code | FR |
| authorships[15].institutions[0].display_name | Hôpital Bichat-Claude-Bernard |
| authorships[15].institutions[1].id | https://openalex.org/I100532134 |
| authorships[15].institutions[1].ror | https://ror.org/029brtt94 |
| authorships[15].institutions[1].type | education |
| authorships[15].institutions[1].lineage | https://openalex.org/I100532134, https://openalex.org/I203339264 |
| authorships[15].institutions[1].country_code | FR |
| authorships[15].institutions[1].display_name | Université Claude Bernard Lyon 1 |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Eric Daugas |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Service de Néphrologie, Assistance publique ‐ Hôpitaux de Paris (AP‐HP), Hôpital Bichat‐Claude Bernard Paris France |
| authorships[16].author.id | https://openalex.org/A5041902083 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-6942-3595 |
| authorships[16].author.display_name | Aurélie Hummel |
| authorships[16].countries | FR |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1288880153 |
| authorships[16].affiliations[0].raw_affiliation_string | Service de Néphrologie, Transplantation Adults, Hôpital Necker‐Enfants Malades Paris France |
| authorships[16].institutions[0].id | https://openalex.org/I1288880153 |
| authorships[16].institutions[0].ror | https://ror.org/05tr67282 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I1288880153, https://openalex.org/I4210097159, https://openalex.org/I4210120235 |
| authorships[16].institutions[0].country_code | FR |
| authorships[16].institutions[0].display_name | Hôpital Necker-Enfants Malades |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Aurélie Hummel |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Service de Néphrologie, Transplantation Adults, Hôpital Necker‐Enfants Malades Paris France |
| authorships[17].author.id | https://openalex.org/A5045427122 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-3030-9506 |
| authorships[17].author.display_name | Rémi Salomon |
| authorships[17].countries | FR |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210097159, https://openalex.org/I4210165077 |
| authorships[17].affiliations[0].raw_affiliation_string | Pediatric Nephrology, Inserm U1163, MARHEA Reference Center Imagine Institute, Paris Cité University, Necker‐Enfants Malades Hospital, APHP Paris France |
| authorships[17].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[17].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[17].institutions[0].country_code | FR |
| authorships[17].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[17].institutions[1].id | https://openalex.org/I154526488 |
| authorships[17].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[17].institutions[1].type | government |
| authorships[17].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[17].institutions[1].country_code | FR |
| authorships[17].institutions[1].display_name | Inserm |
| authorships[17].institutions[2].id | https://openalex.org/I4210165077 |
| authorships[17].institutions[2].ror | https://ror.org/05rq3rb55 |
| authorships[17].institutions[2].type | facility |
| authorships[17].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210100892, https://openalex.org/I4210165077 |
| authorships[17].institutions[2].country_code | FR |
| authorships[17].institutions[2].display_name | Institut des Maladies Génétiques Imagine |
| authorships[17].institutions[3].id | https://openalex.org/I204730241 |
| authorships[17].institutions[3].ror | https://ror.org/05f82e368 |
| authorships[17].institutions[3].type | education |
| authorships[17].institutions[3].lineage | https://openalex.org/I204730241 |
| authorships[17].institutions[3].country_code | FR |
| authorships[17].institutions[3].display_name | Université Paris Cité |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Rémi Salomon |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Pediatric Nephrology, Inserm U1163, MARHEA Reference Center Imagine Institute, Paris Cité University, Necker‐Enfants Malades Hospital, APHP Paris France |
| authorships[18].author.id | https://openalex.org/A5048736345 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-9398-2968 |
| authorships[18].author.display_name | Jean‐Christophe Lega |
| authorships[18].countries | FR |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[18].affiliations[0].raw_affiliation_string | Department of Internal and Vascular Medicine Hospices Civils de Lyon Lyon France |
| authorships[18].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[18].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[18].institutions[0].country_code | FR |
| authorships[18].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Jean‐Christophe Lega |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Department of Internal and Vascular Medicine Hospices Civils de Lyon Lyon France |
| authorships[19].author.id | https://openalex.org/A5072330243 |
| authorships[19].author.orcid | https://orcid.org/0000-0001-6984-762X |
| authorships[19].author.display_name | Stéphane Decramer |
| authorships[19].countries | FR |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I17866349 |
| authorships[19].affiliations[0].raw_affiliation_string | Department of Pediatric Internal Medicine, Rheumatology and Nephrology Toulouse University Hospital Toulouse France |
| authorships[19].institutions[0].id | https://openalex.org/I17866349 |
| authorships[19].institutions[0].ror | https://ror.org/004raaa70 |
| authorships[19].institutions[0].type | education |
| authorships[19].institutions[0].lineage | https://openalex.org/I17866349 |
| authorships[19].institutions[0].country_code | FR |
| authorships[19].institutions[0].display_name | Université Fédérale de Toulouse Midi-Pyrénées |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Stéphane Decramer |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Department of Pediatric Internal Medicine, Rheumatology and Nephrology Toulouse University Hospital Toulouse France |
| authorships[20].author.id | https://openalex.org/A5043853010 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-4902-5332 |
| authorships[20].author.display_name | Alexandre Bélot |
| authorships[20].countries | FR |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[20].affiliations[0].raw_affiliation_string | Pediatric Rheumatology, Nephrology, Dermatology Department, CMR RAISE, Women‐Mother‐Child Hospital, Hospices Civils de Lyon Bron France |
| authorships[20].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[20].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[20].institutions[0].country_code | FR |
| authorships[20].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Alexandre Belot |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Pediatric Rheumatology, Nephrology, Dermatology Department, CMR RAISE, Women‐Mother‐Child Hospital, Hospices Civils de Lyon Bron France |
| authorships[21].author.id | https://openalex.org/A5046988752 |
| authorships[21].author.orcid | |
| authorships[21].author.display_name | Delphine Gobert |
| authorships[21].countries | FR |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I39804081, https://openalex.org/I4210102928 |
| authorships[21].affiliations[0].raw_affiliation_string | Sorbonne Université, service de médecine interne, AP‐HP, Hôpital universitaire Saint Antoine Paris France |
| authorships[21].institutions[0].id | https://openalex.org/I4210102928 |
| authorships[21].institutions[0].ror | https://ror.org/01875pg84 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210102928 |
| authorships[21].institutions[0].country_code | FR |
| authorships[21].institutions[0].display_name | Hôpital Saint-Antoine |
| authorships[21].institutions[1].id | https://openalex.org/I39804081 |
| authorships[21].institutions[1].ror | https://ror.org/02en5vm52 |
| authorships[21].institutions[1].type | education |
| authorships[21].institutions[1].lineage | https://openalex.org/I39804081 |
| authorships[21].institutions[1].country_code | FR |
| authorships[21].institutions[1].display_name | Sorbonne Université |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Delphine Gobert |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Sorbonne Université, service de médecine interne, AP‐HP, Hôpital universitaire Saint Antoine Paris France |
| authorships[22].author.id | https://openalex.org/A5062315921 |
| authorships[22].author.orcid | |
| authorships[22].author.display_name | N. Costedoat‐Chalumeau |
| authorships[22].countries | FR |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210092774 |
| authorships[22].affiliations[0].raw_affiliation_string | Centre de référence maladies auto‐immunes et systémiques rares de l'île de France, Cochin Hospital Paris France |
| authorships[22].institutions[0].id | https://openalex.org/I4210092774 |
| authorships[22].institutions[0].ror | https://ror.org/00ph8tk69 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I4210092774, https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[22].institutions[0].country_code | FR |
| authorships[22].institutions[0].display_name | Hôpital Cochin |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Nathalie Costedoat‐Chalumeau |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Centre de référence maladies auto‐immunes et systémiques rares de l'île de France, Cochin Hospital Paris France |
| authorships[23].author.id | https://openalex.org/A5040540371 |
| authorships[23].author.orcid | https://orcid.org/0000-0003-0553-0927 |
| authorships[23].author.display_name | Stanislas Faguer |
| authorships[23].countries | FR |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210167250 |
| authorships[23].affiliations[0].raw_affiliation_string | Department of Nephrology and Organ Transplantation University Hospital of Toulouse, French Intensive Care Renal Network Toulouse France |
| authorships[23].institutions[0].id | https://openalex.org/I4210167250 |
| authorships[23].institutions[0].ror | https://ror.org/05xw0wj25 |
| authorships[23].institutions[0].type | facility |
| authorships[23].institutions[0].lineage | https://openalex.org/I4210167250 |
| authorships[23].institutions[0].country_code | FR |
| authorships[23].institutions[0].display_name | French Clinical Research Infrastructure Network |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Stanislas Faguer |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Department of Nephrology and Organ Transplantation University Hospital of Toulouse, French Intensive Care Renal Network Toulouse France |
| authorships[24].author.id | https://openalex.org/A5012048977 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-8057-333X |
| authorships[24].author.display_name | Isabelle Melki |
| authorships[24].countries | FR |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I204730241, https://openalex.org/I4210091437, https://openalex.org/I4210097159 |
| authorships[24].affiliations[0].raw_affiliation_string | General Paediatrics, Department of Infectious Disease and Internal Medicine Robert Debré University Hospital, APHP, Nord‐Université Paris Cité Paris France |
| authorships[24].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[24].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[24].institutions[0].type | healthcare |
| authorships[24].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[24].institutions[0].country_code | FR |
| authorships[24].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[24].institutions[1].id | https://openalex.org/I4210091437 |
| authorships[24].institutions[1].ror | https://ror.org/001z21q04 |
| authorships[24].institutions[1].type | other |
| authorships[24].institutions[1].lineage | https://openalex.org/I4210091437 |
| authorships[24].institutions[1].country_code | FR |
| authorships[24].institutions[1].display_name | Sorbonne Paris Cité |
| authorships[24].institutions[2].id | https://openalex.org/I204730241 |
| authorships[24].institutions[2].ror | https://ror.org/05f82e368 |
| authorships[24].institutions[2].type | education |
| authorships[24].institutions[2].lineage | https://openalex.org/I204730241 |
| authorships[24].institutions[2].country_code | FR |
| authorships[24].institutions[2].display_name | Université Paris Cité |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Isabelle Melki |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | General Paediatrics, Department of Infectious Disease and Internal Medicine Robert Debré University Hospital, APHP, Nord‐Université Paris Cité Paris France |
| authorships[25].author.id | https://openalex.org/A5018755487 |
| authorships[25].author.orcid | https://orcid.org/0000-0001-9315-1577 |
| authorships[25].author.display_name | Noémie Jourde‐Chiche |
| authorships[25].countries | FR |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210087487 |
| authorships[25].affiliations[0].raw_affiliation_string | Department of Nephrology, AP‐ Marseille HM France |
| authorships[25].institutions[0].id | https://openalex.org/I4210087487 |
| authorships[25].institutions[0].ror | https://ror.org/002cp4060 |
| authorships[25].institutions[0].type | healthcare |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210087487 |
| authorships[25].institutions[0].country_code | FR |
| authorships[25].institutions[0].display_name | Assistance Publique Hôpitaux de Marseille |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Noémie Jourde‐Chiche |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Department of Nephrology, AP‐ Marseille HM France |
| authorships[26].author.id | https://openalex.org/A5046909004 |
| authorships[26].author.orcid | https://orcid.org/0000-0001-8476-8196 |
| authorships[26].author.display_name | Brigitte Bader‐Meunier |
| authorships[26].countries | FR |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I4210165077 |
| authorships[26].affiliations[0].raw_affiliation_string | Department of Pediatric Immunology Hematology and Rheumatology, Necker Hospital, AP‐HP, National Reference Centre for Rheumatic and Autoimmune Diseases in Children, RAISE, Institut IMAGINE Paris France |
| authorships[26].institutions[0].id | https://openalex.org/I4210165077 |
| authorships[26].institutions[0].ror | https://ror.org/05rq3rb55 |
| authorships[26].institutions[0].type | facility |
| authorships[26].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I4210100892, https://openalex.org/I4210165077 |
| authorships[26].institutions[0].country_code | FR |
| authorships[26].institutions[0].display_name | Institut des Maladies Génétiques Imagine |
| authorships[26].author_position | last |
| authorships[26].raw_author_name | Brigitte Bader‐Meunier |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Department of Pediatric Immunology Hematology and Rheumatology, Necker Hospital, AP‐HP, National Reference Centre for Rheumatic and Autoimmune Diseases in Children, RAISE, Institut IMAGINE Paris France |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bcp.70103 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10308 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2745 |
| primary_topic.subfield.display_name | Rheumatology |
| primary_topic.display_name | Systemic Lupus Erythematosus Research |
| related_works | https://openalex.org/W4240885715, https://openalex.org/W1912221966, https://openalex.org/W2052896144, https://openalex.org/W1975848259, https://openalex.org/W1982830518, https://openalex.org/W2304344236, https://openalex.org/W2377489426, https://openalex.org/W2082998857, https://openalex.org/W2367999783, https://openalex.org/W2090307551 |
| cited_by_count | 0 |
| locations_count | 5 |
| best_oa_location.id | doi:10.1002/bcp.70103 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S13842274 |
| best_oa_location.source.issn | 0306-5251, 1365-2125 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0306-5251 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | British Journal of Clinical Pharmacology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bcp.70103 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | British Journal of Clinical Pharmacology |
| best_oa_location.landing_page_url | https://doi.org/10.1002/bcp.70103 |
| primary_location.id | doi:10.1002/bcp.70103 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S13842274 |
| primary_location.source.issn | 0306-5251, 1365-2125 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0306-5251 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | British Journal of Clinical Pharmacology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bcp.70103 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | British Journal of Clinical Pharmacology |
| primary_location.landing_page_url | https://doi.org/10.1002/bcp.70103 |
| publication_date | 2025-05-23 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4292232933, https://openalex.org/W2012199712, https://openalex.org/W2063860263, https://openalex.org/W1914202058, https://openalex.org/W1995478520, https://openalex.org/W1981881616, https://openalex.org/W78466469, https://openalex.org/W2146522063, https://openalex.org/W2091277908, https://openalex.org/W2070484917, https://openalex.org/W2196064518, https://openalex.org/W2987819628, https://openalex.org/W2165123601, https://openalex.org/W91521388, https://openalex.org/W2010091270, https://openalex.org/W1886199714, https://openalex.org/W4309705489, https://openalex.org/W2980400773, https://openalex.org/W2039896702, https://openalex.org/W1966850492, https://openalex.org/W2059738633, https://openalex.org/W2060862416, https://openalex.org/W2097744968, https://openalex.org/W2006151388, https://openalex.org/W1987946536, https://openalex.org/W2429386115, https://openalex.org/W4387569385, https://openalex.org/W2166521431, https://openalex.org/W2086572104, https://openalex.org/W1487151943, https://openalex.org/W2023514659, https://openalex.org/W2023518835, https://openalex.org/W2086200357, https://openalex.org/W2033539543 |
| referenced_works_count | 34 |
| abstract_inverted_index.3 | 204 |
| abstract_inverted_index.A | 66 |
| abstract_inverted_index.a | 4, 43, 106, 231 |
| abstract_inverted_index.54 | 171 |
| abstract_inverted_index.66 | 69 |
| abstract_inverted_index.at | 203 |
| abstract_inverted_index.in | 8, 28, 32, 47, 227, 239 |
| abstract_inverted_index.is | 3, 16, 26 |
| abstract_inverted_index.kg | 174 |
| abstract_inverted_index.of | 11, 24, 37, 68, 154, 242 |
| abstract_inverted_index.on | 143 |
| abstract_inverted_index.or | 222 |
| abstract_inverted_index.to | 41, 54, 125, 138, 160, 187, 229, 234 |
| abstract_inverted_index.up | 80 |
| abstract_inverted_index.235 | 176 |
| abstract_inverted_index.SLE | 71 |
| abstract_inverted_index.The | 35, 102, 163 |
| abstract_inverted_index.and | 59, 74, 78, 94, 120, 152, 175, 206, 224 |
| abstract_inverted_index.are | 215, 225 |
| abstract_inverted_index.did | 209 |
| abstract_inverted_index.for | 117 |
| abstract_inverted_index.its | 14, 29, 60 |
| abstract_inverted_index.kg, | 179 |
| abstract_inverted_index.lag | 112 |
| abstract_inverted_index.not | 197, 216 |
| abstract_inverted_index.the | 9, 21, 33, 95, 115, 182, 191, 240 |
| abstract_inverted_index.was | 40, 105, 185, 196 |
| abstract_inverted_index.who | 201, 208 |
| abstract_inverted_index.yet | 217 |
| abstract_inverted_index.(242 | 82 |
| abstract_inverted_index.(95% | 167 |
| abstract_inverted_index.Aims | 1 |
| abstract_inverted_index.Free | 148 |
| abstract_inverted_index.L/70 | 178 |
| abstract_inverted_index.SLE. | 243 |
| abstract_inverted_index.This | 129 |
| abstract_inverted_index.body | 161 |
| abstract_inverted_index.both | 118 |
| abstract_inverted_index.data | 96 |
| abstract_inverted_index.drug | 237 |
| abstract_inverted_index.form | 31, 127 |
| abstract_inverted_index.free | 30, 56, 132 |
| abstract_inverted_index.from | 122 |
| abstract_inverted_index.goal | 36 |
| abstract_inverted_index.make | 230 |
| abstract_inverted_index.not. | 210 |
| abstract_inverted_index.open | 108 |
| abstract_inverted_index.then | 136 |
| abstract_inverted_index.this | 38 |
| abstract_inverted_index.time | 113 |
| abstract_inverted_index.used | 6, 137 |
| abstract_inverted_index.were | 76, 88, 97, 135, 157, 170 |
| abstract_inverted_index.with | 49, 62, 110, 190 |
| abstract_inverted_index.(SLE) | 53 |
| abstract_inverted_index.based | 142 |
| abstract_inverted_index.delay | 116 |
| abstract_inverted_index.dose. | 192 |
| abstract_inverted_index.found | 27, 186 |
| abstract_inverted_index.lupus | 51 |
| abstract_inverted_index.model | 46, 104, 109, 130 |
| abstract_inverted_index.often | 17 |
| abstract_inverted_index.order | 228 |
| abstract_inverted_index.study | 39 |
| abstract_inverted_index.those | 207 |
| abstract_inverted_index.total | 67, 140 |
| abstract_inverted_index.using | 90, 99 |
| abstract_inverted_index.which | 134 |
| abstract_inverted_index.(Vu/F) | 156 |
| abstract_inverted_index.L/h/70 | 173 |
| abstract_inverted_index.Plasma | 85 |
| abstract_inverted_index.Robust | 212 |
| abstract_inverted_index.active | 22, 70, 126 |
| abstract_inverted_index.dosing | 15 |
| abstract_inverted_index.liquid | 91 |
| abstract_inverted_index.lupus, | 12 |
| abstract_inverted_index.months | 205 |
| abstract_inverted_index.scaled | 158 |
| abstract_inverted_index.serum. | 34 |
| abstract_inverted_index.volume | 153 |
| abstract_inverted_index.widely | 5 |
| abstract_inverted_index.(CLu/F) | 151 |
| abstract_inverted_index.(adults | 73 |
| abstract_inverted_index.Methods | 65 |
| abstract_inverted_index.Monolix | 100 |
| abstract_inverted_index.Results | 147 |
| abstract_inverted_index.between | 199 |
| abstract_inverted_index.binding | 145 |
| abstract_inverted_index.clearly | 218 |
| abstract_inverted_index.context | 241 |
| abstract_inverted_index.defined | 219 |
| abstract_inverted_index.develop | 42 |
| abstract_inverted_index.disease | 63 |
| abstract_inverted_index.targets | 214 |
| abstract_inverted_index.typical | 164 |
| abstract_inverted_index.weight. | 162 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.although | 13 |
| abstract_inverted_index.analysed | 98 |
| abstract_inverted_index.assessed | 89 |
| abstract_inverted_index.decrease | 188 |
| abstract_inverted_index.efficacy | 223 |
| abstract_inverted_index.exposure | 195 |
| abstract_inverted_index.followed | 79 |
| abstract_inverted_index.forecast | 55 |
| abstract_inverted_index.inactive | 123 |
| abstract_inverted_index.patients | 48, 72, 200 |
| abstract_inverted_index.systemic | 50 |
| abstract_inverted_index.toxicity | 221 |
| abstract_inverted_index.valuable | 232 |
| abstract_inverted_index.(48–62) | 172 |
| abstract_inverted_index.activity. | 64 |
| abstract_inverted_index.calculate | 139 |
| abstract_inverted_index.children) | 75 |
| abstract_inverted_index.clearance | 150 |
| abstract_inverted_index.different | 198 |
| abstract_inverted_index.estimates | 166 |
| abstract_inverted_index.included, | 77 |
| abstract_inverted_index.interval) | 169 |
| abstract_inverted_index.parameter | 184 |
| abstract_inverted_index.predicted | 131 |
| abstract_inverted_index.regarding | 220 |
| abstract_inverted_index.responded | 202 |
| abstract_inverted_index.software. | 101 |
| abstract_inverted_index.treatment | 10 |
| abstract_inverted_index.warranted | 226 |
| abstract_inverted_index.Prednisone | 2 |
| abstract_inverted_index.absorption | 111, 119 |
| abstract_inverted_index.confidence | 168 |
| abstract_inverted_index.constants. | 146 |
| abstract_inverted_index.cumulative | 194 |
| abstract_inverted_index.determined | 18 |
| abstract_inverted_index.metabolism | 121 |
| abstract_inverted_index.metabolite | 23 |
| abstract_inverted_index.monitoring | 238 |
| abstract_inverted_index.population | 44, 165 |
| abstract_inverted_index.(203–274) | 177 |
| abstract_inverted_index.Conclusions | 211 |
| abstract_inverted_index.association | 61 |
| abstract_inverted_index.available). | 84 |
| abstract_inverted_index.established | 144 |
| abstract_inverted_index.prednisone, | 25 |
| abstract_inverted_index.therapeutic | 236 |
| abstract_inverted_index.(prednisone) | 124 |
| abstract_inverted_index.Prednisolone | 193 |
| abstract_inverted_index.contribution | 233 |
| abstract_inverted_index.distribution | 155 |
| abstract_inverted_index.empirically. | 19 |
| abstract_inverted_index.observations | 83 |
| abstract_inverted_index.prednisolone | 57, 86, 149, 235 |
| abstract_inverted_index.representing | 114 |
| abstract_inverted_index.Additionally, | 181 |
| abstract_inverted_index.Prednisolone, | 20 |
| abstract_inverted_index.erythematosus | 52 |
| abstract_inverted_index.prospectively | 81 |
| abstract_inverted_index.respectively. | 180 |
| abstract_inverted_index.spectrometry, | 93 |
| abstract_inverted_index.allometrically | 159 |
| abstract_inverted_index.concentrations | 58, 87, 141 |
| abstract_inverted_index.glucocorticoid | 7 |
| abstract_inverted_index.non‐linearly | 189 |
| abstract_inverted_index.(prednisolone). | 128 |
| abstract_inverted_index.bioavailability | 183 |
| abstract_inverted_index.concentrations, | 133 |
| abstract_inverted_index.pharmacokinetic | 45, 103, 213 |
| abstract_inverted_index.one‐compartment | 107 |
| abstract_inverted_index.chromatography‐mass | 92 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 27 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7900000214576721 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.2779915 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |